Announcements & Events

June 16,2015 – Dermatologists have long known that available treatments for chronic itch, including eczema, are simply not up to scratch. But scientists have now discovered a new gene that promotes itch, suggesting a way forward for powerful new therapies.

Read More


June 8, 2015 – I have been a part of the eczema community, and the NEA Board of Directors, for many years I never thought I would see the day when hope and opportunity would converge and we would see a promising future for eczema on the horizon. That day is now!

Read More


May 29, 2015 – Linalyl acetate, a fragrance chemical that is one of the main constituents of the essential oil of lavender, is not on the list of allergenic compounds pursuant to the EU Cosmetics Directive. Thus, it does not need to be declared on cosmetic products sold within the EU. Recent studies at the University of Gothenburg have shown that linalyl acetate can cause allergic eczema.

Read More


May 22, 2015 – “Eczema keeps me from doing things that other people enjoy all the time, like going to the beach, riding my bike, going for a walk, and enjoying being outside,” says 13-year-old eczema patient, Isaiah Dixon. But that didn’t stop Isaiah from testifying in March at a Food and Drug Administration (FDA) hearing in Silver Spring, MD, on behalf of the National Eczema Association.

Read More


NEA formed a Scientific Advisory Committee Task Force to conduct a systematic review of topical corticosteroid withdrawal/topical steroid addiction in patients with atopic dermatitis and other dermatoses, and created a NEA education announcement on Topical Steroid Addiction/Withdrawal.

Read More


March 10, 2015 – On March 9, 2015, NEA CEO Julie Block, 13-year old eczema patient Isaiah, 17-year old eczema patient Gracie, and their parents were present at an important Food and Drug Administrative (FDA) hearing regarding the unmet medical need for atopic dermatitis therapies in pediatrics.

Read More


March 10, 2015 – Step toward a cure for eczema with us – be an eczema advocate and advance research!

Read More


January 6, 2015 – For the first time, a team led by researchers at the Icahn School of Medicine at Mount Sinai has proven that atopic dermatitis, also known as eczema, is an immune-driven (autoimmune) disease.

Read More


December 16, 2014 – Archive of Hope for Eczema: New Treatment Developments is now available.

Read More


December 15, 2014 – Patients on subcutaneous dupilumab at 300 mg once weekly showed nearly an 80% reduction from baseline in Eczema Area and Severity Index scores after 16 weeks of treatment.

Read More